For a treatment choice the early identification of non-ST myocardial infarction segment patients (NSTEMI) with poor in-hospital results is essential. The CHA2DS2-VASc-HS and CHA2DS2-VASc score was recently reported as a predictor of severity and poor outcomes in individuals with stable coronary artery disease (CAD) and acute coronary syndrome. Our research aimed at evaluating the precision of the CHA2DS2-VASc-HS score, which predicts poor outcomes in hospitals in NSTEMI patients. 120 NSTEMI patients have been enrolled. The score for CHA2DS2-VASc-HS has been computed. The participants of the research were split into two groups. Group I and Group II score <4 were placed in Patients with CHA2DS2-VASc-HS score>4. Patients with CHA2DS2-VASc-HS >4 were found to have higher unfavourable outcomes in the hospital than the CHA2DS2-VASc-HS score <4.
Mahmoud, M., Kabil, H., Ebed, H., & Sabry, A. (2021). The value of CHA2DS2-VASc-HS score for prediction of adverse in-hospital outcomes in patients with non-ST segment elevation myocardial infarction. Benha Journal of Applied Sciences, 6(4), 191-196. doi: 10.21608/bjas.2021.189923
MLA
M.K. Mahmoud; H.M. Kabil; H.H. Ebed; A.M. Sabry. "The value of CHA2DS2-VASc-HS score for prediction of adverse in-hospital outcomes in patients with non-ST segment elevation myocardial infarction", Benha Journal of Applied Sciences, 6, 4, 2021, 191-196. doi: 10.21608/bjas.2021.189923
HARVARD
Mahmoud, M., Kabil, H., Ebed, H., Sabry, A. (2021). 'The value of CHA2DS2-VASc-HS score for prediction of adverse in-hospital outcomes in patients with non-ST segment elevation myocardial infarction', Benha Journal of Applied Sciences, 6(4), pp. 191-196. doi: 10.21608/bjas.2021.189923
VANCOUVER
Mahmoud, M., Kabil, H., Ebed, H., Sabry, A. The value of CHA2DS2-VASc-HS score for prediction of adverse in-hospital outcomes in patients with non-ST segment elevation myocardial infarction. Benha Journal of Applied Sciences, 2021; 6(4): 191-196. doi: 10.21608/bjas.2021.189923
)
View on SCiNiTO